Several studies have demonstrated that loss of GPx3 expression within tumor tissues is associated with poor patient prognosis and chemotherapeutic resistance (Table 1) [61,62,63,86,87,109,110,111,112,113,114,115]. Here, GPX3 is linked to neoplasm.